Author

M. Powell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Organism:Drosophila· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Castillo· 1 shared A. Howard-Cunningham· 1 shared A. N. Smith· 1 shared A. Zhang· 1 shared B. Drawert· 1 shared B. Fisher· 1 shared B. Rumsey· 1 shared G. W. Booz· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Castillo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Intrauterine Growth-Restricted Pregnant Rats, from Hypertensive Placental Ischemic Dams Display Preeclamptic-like Symptoms: A New Rodent Model of Preeclampsia

J. Smith, M. Powell, W. Cromartie, S. Smith, K. Jones, A. Castillo, J. Shaw, J. Editone, A. Howard-Cunningham, R. Tatum, A. N. Smith, B. Fisher, G. W. Booz, M. W. CUNNINGHAM

This study establishes a new rodent model of preeclampsia by inducing intrauterine growth restriction in pregnant rats, showing elevated blood pressure and oxidative stress.

bioRxiv · Feb 7, 2024 · PreprintPhysiology

Saving the Devils is in the details: Tasmanian Devil facial tumor disease can be eliminated with interventions

B. Drawert, S. Matthew, M. Powell, B. Rumsey

This paper develops a computational model to evaluate intervention strategies for Tasmanian Devil facial tumor disease and finds that combining strategies yields the best outcomes.

bioRxiv · Apr 3, 2022 · PreprintEcology

A Novel Xenonucleic Acid Mediated Molecular Clamping Technology for Early Colorectal Cancer Screening

Q. Sun, L. Pastor, J. Du, M. Powell, A. Zhang, W. Bodmer, J. Wu, S. Zheng, M. Y. Sha

This paper develops a molecular clamping assay called ColoScape for early colorectal cancer detection using XNA-mediated qPCR, showing high sensitivity and specificity in clinical samples.

bioRxiv · May 15, 2020Cancer Biology